Lybrel FDA Approval History
FDA Approved: Yes (Discontinued) (First approved May 22, 2007)
Brand name: Lybrel
Generic name: levonorgestrel and ethinyl estradiol
Dosage form: Tablets
Company: Wyeth Pharmaceuticals Inc.
Treatment for: Birth Control
Marketing Status: Discontinued
Lybrel (levonorgestrel and ethinyl estradiol) is a low-dose combination contraceptive pill taken continuously (without a pill-free interval) and over time may eliminate scheduled menstrual periods. Lybrel is indicated for the prevention of pregnancy.
Development Timeline for Lybrel
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.